Transpulmonary Pressure-Guided Ventilation for Right Heart Protection in ARDS
Official title: Application of Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With Acute Respiratory Distress Syndrome Caused by Pneumonia
Run by Beijing Chao Yang Hospital · NCT07490925 · Data updated 2026-11-12
This study tests whether using transpulmonary pressure to guide ventilation can reduce right heart involvement in adults with pneumonia-related moderate to severe ARDS.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | Beijing Chao Yang Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | March 23, 2026 |
| Main results expected | March 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | September 14, 2026 |
| Trial ID | NCT07490925 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with pneumonia-induced moderate to severe ARDS on invasive mechanical ventilation.
✕Probably not a fit
Patients with esophageal catheter contraindications or other high-risk factors may not benefit and could be at risk.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this interventional trial, researchers will apply a ventilation strategy guided by transpulmonary pressure to patients with pneumonia-induced ARDS and compare its effects on the right ventricle to the standard right-ventricle–protective approach. Eligible patients are adults with ARDS and PaO2/FiO2 ≤ 200 on invasive mechanical ventilation. The aim is to see if the transpulmonary-guided strategy lowers the incidence of acute cor pulmonale and other right-heart complications. The trial is conducted at Beijing Chao-Yang Hospital and involves careful monitoring and esophageal pressure measurement to tailor ventilator settings. Safety considerations include exclusion of patients with conditions that could confound measurements or increase risk, such as high intracranial pressure or active air leakage in the lungs.
Why it matters
Potential benefit: If successful, patients may experience better right-heart function and potentially improved outcomes during severe ARDS.
How similar studies have gone: Previous work in targeting transpulmonary pressure shows promise for lung protection; this study extends the approach to right-heart protection in ARDS.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years old 2. ARDS caused by pneumonia (New Global Definition of ARDS) 3. PaO2/FiO2≤200mmHg 4. Received invasive mechanical ventilation 5. Sign the informed consent form Exclusion Criteria: 1. Invasive mechanical ventilation duration \> 48 hours 2. History of pulmonary hypertension caused by various reasons 3. Severe arrhythmia 4. BMI\>30kg/m2 5. Contraindications to inserting an esophageal catheter (including recent esophageal injury or surgery, severe coagulopathy (platelets \< 5×10⁹/L or INR \> 4) 6. Pregnant and lactating women 7. Lung transplant recipient 8. High-risk factors for increased intracranial pressure (including intracranial hemorrhage, cerebral contusion, cerebral edema, intracranial space-occupying lesions, etc.) 9. Active air leakage in the lungs (pneumothorax, mediastinal emphysema, bronchopleural fistula, air leakage from closed thoracic drainage tubes, etc.) 10. Neuromuscular disease 11. Already received salvage measures (iNO, ECMO, prone position, high-frequency oscillatory ventilation) 12. Severe liver failure 13. Participated in other ARDS-related studies within 30 days
Where it's running
-
Beijing Chao-Yang Hospital
Beijing, China Recruiting
Study contacts
- Study coordinator: Xiao Tang, MD
- Email: tangxiao0928@163.com
- Phone: 86013811089795
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Single-dose inhaled rh-KGF-2 for ARDS in adults
This trial tests whether a single inhaled dose of rh-KGF-2 helps adults with ARDS who are on ventilators, using three dose levels to see which is safest and potentially most effective.
-
How changing PEEP affects breathing drive and effort during pressure‑support ventilation
We will test whether changing PEEP levels changes neural respiratory drive and inspiratory effort in adults on pressure‑support ventilation for moderate‑to‑severe ARDS or acute hypoxemic respiratory failure.
-
PRE-VAIL: reducing enteral feeding before prone positioning for severe ARDS
This trial tests whether temporarily reducing tube feeding before turning adults with moderate-to-severe ARDS onto their stomachs lowers stomach pressure and feeding problems.
-
Using prone positioning to predict neurological complications in ARDS patients
This study looks at patients with severe breathing problems who are treated by lying on their stomachs to see if this position can help predict any brain issues they might have.
-
Diaphragm stimulation to improve breathing in ICU patients on ventilators
This study is testing if a new way of stimulating the diaphragm can help ICU patients on ventilators breathe better compared to standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.